Skip to main content
. 2019 Dec 16;49(6):1674–1680. doi: 10.3906/sag-1904-49

Table 1.

Clinical, biochemical, and bone mineral densitometry parameters of patients with asymptomatic and symptomatic primary hyperparathyroidism before parathyroidectomy.

Variables Asymptomatic PHPT, n = 63 Symptomatic PHPT, n = 28 P
Women (%) 82.8 77.8 0.314
Menopause (%) 61.5 61.9 0.815
Smoking habit (%) 20.6 25.9 0.715
Age (years) 51.52 ± 10.47 52.40 ± 11.59 0.826
BMI (kg/m2) 29.95 ± 4.72 32.13 ± 6.60 0.482
Glucose (mg/dL) 90.85 ± 9.99 89.60 ± 9.01 0.934
Albumin (mg/dL) 4.53 ± 0.22 4.41 ± 0.15 0.352
Creatinine (mg/dL) 0.75 ± 0.15 0.68 ± 0.16 0.408
Calcium (mg/dL) 10.41 ± 0.64 11.34 ± 0.76 <0.001
Phosphorus (mg/dL) 2.61 ± 0.37 2.50 ± 0.44 0.030
iPTH (pg/dL) 194.76 ± 136.63 347.53 ± 202.24 <0.001
ALP (mg/dL) 101.52 ± 40.08 158.20 ± 74.90 <0.001
25(OH)D (ng/mL) 20.15 ± 24.11 9.82 ± 9.13 0.003
Magnesium (mg/dL) 2.13 ± 0.19 2.12 ± 0.23 0.935
TSH (mg/dL) 2.09 ± 1.29 1.56 ± 0.81 0.728
Lumbar spine BMD (g/cm2) 0.83 ± 0.15 0.72 ± 0.12 0.137
Total hip BMD (g/cm2) 0.78 ± 0.13 0.71 ± 0.15 0.951
Femoral neck BMD (g/cm2) 0.67 ± 0.11 0.63 ± 0.09 0.879
Lumbar spine T-score –1.99 ± 1.41 –2.92 ± 1.17 0.020
Total hip T-score –1.44 ± 1.14 –1.98 ± 1.30 0.242
Femoral neck T-score –1.83 ± 1.17 –2.32 ± 1.09 0.165
Osteoporosis at lumbar spine (%) 37.5 63.0 0.026
Osteoporosis at total hip (%) 12.5 29.6 0.050
Osteoporosis at femoral neck (%) 20.6 40.7 0.048
Osteoporosis at least one site (%) 39.1 66.7 0.016
Nephrolithiasis (%) 4.6 18.2 0.032
Urinary calcium excretion (mg/24 h) 362.61 ± 175.20 437.33 ± 87.18 0.016
Adenoma volume (cm3) 0.47 ± 0.56 2.95 ± 3.49 0.027

Continuous variables are presented as mean ± standard deviation (SD). Categorical variables are presented as percentage (%).

BMI, Body mass index; TSH, thyroid-stimulating hormone; ALP, alkaline phosphatase; iPTH, intact parathyroid hormone, BMD, bone mineral density; 25(OH)D, 25-hydroxy-vitamin D.